Session Details

JSNM Oral 27:Drug discovery and development 3

Sat. Nov 15, 2025 9:00 AM - 10:10 AM JST
Sat. Nov 15, 2025 12:00 AM - 1:10 AM UTC
Room 2(1F, Exhibition Hall 2 A, Kyoto International Exhibition Hall 'Miyako Messe')
座長:鷲山 幸信(福島県立医科大学 先端臨床研究センター)、清野 泰(福井大学 高エネルギー医学研究センター)

[3-MO27-1]Radiosynthesis and evaluation of new PET probes for imaging of LRRK2

Wakana Mori1、Nobuki Nengaki1,2、Masanao Ogawa1,2、Tomoteru Yamasaki1、Masayuki Fujinaga1、Ming-Rong Zhang1 (1.Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba, Japan、2.SHI Accelerator Service Ltd., Tokyo, Japan)

[3-MO27-2]First-in-Human study of a Novel CAIX-Targeting Probe in Clear Cell Renal Cell Carcinoma

Toshihiro Horii1,2、Mitsuyoshi Yoshimoto2、Akinori Kobayashi2、Kimiteru Ito3、Natsuki Honda4、Masato Murakami5,6、Naoki Kanazawa6、Daisuke Kano7、Akira Inagaki8、Tatsushi Kobayashi8、Anri Inaki1,2 (1.Department of Diagnostic Radiology, NCCHE、2.Division of Functional Imaging, NCC-EPOC、3.Department of Diagnostic Radiology, NCCH、4.Department of Pharmacy, NCCH、5.PeptiDream Inc.、6.PDR Pharma Inc、7.Department of Pharmacy, NCCHE、8.Department of Radiological Technology, Radiological Diagnosis, NCCHE)

[3-MO27-3]Investigation of [18F]4-Fluoro-L-Phenylalanine Synthesis Using an Automated Synthesizer

Kenta Kurimoto1,2、Sadahiro Naka1,2、Masaharu Wakahara3、Daisuke Kinoshita3、Yuta Yasuda3、Jun Hatazawa4、Kayako Isohashi1 (1.Department of Radiology The University of Osaka graduate school of medicine、2.The University of Osaka hospital department of pharmacy、3.SHI Accelerator Service、4.Research center for nuclear physics, University of Osaka)

[3-MO27-4]Development of a radiotheranostics drug targeting the epithelial cell adhesion molecule

Sato Oshige1、Takumi Iwasawa2、Marina Omokawa3、Yoji Kitamura4、Takashi Kozaka4、Yusuke Yagi5、Takiko Daikoku4、Kazunori Kato6、Hiroyuki Kimura7 (1.Graduate School of Medical Sciences, Kanazawa University, Ishikawa, Japan、2.Institute of Life Innovation Studies, TOYO University, Tokyo, Japan、3.Okayama Medical Innovation Center, Okayama University , Okayama, Japan、4.Division of Animal Disease Model, Kanazawa University, Ishikawa, Japan、5.Kyoto University of Medical Science, Kyoto, Japan、6.Guraduate School of Health and Sports Sciences, TOYO University, Tokyo, Japan、7.Division of Environmental Management, Agency for Health, Safety and Environment, Kyoto University, Kyoto, Japan)

[3-MO27-5]Novel PSMA-targeted radioligand with two chemical units that control the pharmacokinetics

Takuma Hasegawa、Kazuma Nakashima、Hiroyuki Watanabe、Masahiro Ono (Department of Patho-Functional Bioanalysis, Kyoto University, Kyoto, Japan.)

[3-MO27-6]Development of a thermosensitive liposomal probe for Auger electron therapy

Kazuki Matsunaga1、Masayuki Munekane1、Miki Ozaki1、Takeshi Fuchigami1、Kenji Mishiro1、Akira Makino2、Yasushi Kiyono2、Kazuma Ogawa1 (1.Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan、2.Biomedical Imaging Research Center, Fukui University, Fukui, Japan)

[3-MO27-7]Investigation of cytotoxicity and immunogenic cell death induced by211At-MABG

Keita Iida1、Akari Mukaimine2、Kohei Nakajima3、Mikako Ogawa2,3 (1.Faculty of Pharmaceutical Sciences, Hokkaido University, Hokkaido, Japan、2.Institute for Chemical Reaction Design and Discovery, Hokkaido University, Hokkaido, Japan、3.Graduate School of Pharmaceutical Sciences, Hokkaido University, Hokkaido, Japan)